Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

76.50
-5.4000-6.59%
Post-market: 76.530.0300+0.04%19:59 EDT
Volume:7.18M
Turnover:561.21M
Market Cap:13.89B
PE:-53.36
High:82.81
Open:81.98
Low:75.92
Close:81.90
52wk High:104.32
52wk Low:40.77
Shares:181.56M
Float Shares:115.00M
Volume Ratio:0.99
T/O Rate:6.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4337
EPS(LYR):-1.4100
ROE:-67.44%
ROA:-8.55%
PB:31.22
PE(LYR):-54.26

Loading ...

Tempus AI Launches Initiative To Build A Million-Genome Dataset!

Bellwether Stocks Movement
·
Sep 14

Anthropic Inks $13.7 Billion Computing-Power Pact With "Trump-Linked" Rum Group

Options & Short Sell
·
Sep 14

Trump Hits The Gas As Silicon Valley Reaches For The Brakes

AI Industry Frontlines
·
Sep 14

Anthropic CEO Urges Slowing The AI Model Race; Musk, Altman Voice Support

AI Industry Frontlines
·
Sep 13

Tempus AI to build multimodal whole-genome dataset for AI-driven healthcare

TIPRANKS
·
Sep 11

Tempus AI Launches Effort to Build 100,000 Whole-Genome Dataset Linked to Clinical Outcomes

Reuters
·
Sep 11

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

THOMSON REUTERS
·
Sep 11

Tempus AI, - General Availability of Dataset Planned for Mid-2027

THOMSON REUTERS
·
Sep 11

$1M → $7B ARR In 10Y! Databricks On Enterprise AI Moat

Bellwether Stocks Movement
·
Sep 11

Anthropic: 3 AI Economic Scenarios to 2030, 15% YoY Growth in Bull Case

AI Industry Frontlines
·
Sep 11

HSBC Says The AI Trade's Next Chapter Hinges On One Word: Monetization

Analyst Calls
·
Sep 10

Tempus AI awarded up to $9.5M from ARPA-H for autonomous AI in cardiology

TIPRANKS
·
Sep 10

Tempus AI Wins up to $9.5 Million ARPA-H Advocate Award for Autonomous Heart Failure Agent

Reuters
·
Sep 10

Tempus Secures up to $9.5 Million in Arpa-H Advocate Funding to Deploy First Autonomous AI in Cardiology

THOMSON REUTERS
·
Sep 10

Tempus AI Initiated at Neutral by UBS

Dow Jones
·
Sep 09

UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target

MT Newswires Live
·
Sep 09

Tempus AI Price Target Announced at $67.00/Share by Roth Capital

Dow Jones
·
Sep 08

Rothschild & Co Redburn Initiates Tempus AI at Neutral With $67 Price Target

MT Newswires Live
·
Sep 08

Arm's Haas: AI Could Cure Cancer In Our Lifetime — If The Industry Can Build Enough Chips

AI Industry Frontlines
·
Sep 08

Kospi Down 27%, Goldman Still Says 12,000: "The Market Is Underpricing This Cycle"

Analyst Calls
·
Sep 07